Tag: Cancer: Pancreatic
USPSTF Reaffirms Recs Against Screening for Pancreatic Cancer
Potential benefits of screening do not outweigh potential harms in asymptomatic adults
Higher Fasting Plasma Glucose May Up Pancreatic Cancer Risk
Continuous increase in risk of pancreatic cancer with elevating fasting glucose, even within normal range
Novel Test Accurately Identifies Precancerous Pancreatic Cysts
Cyst classifier test is based on clinical and imaging features, genetic and biochemical markers
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
Likelihood of cancer-directed therapy higher for first consult with medical, radiation oncology versus surgery
Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma
AACR: High BMI Before 50 Raising Pancreatic Cancer Mortality
Twenty-eight percent of pancreatic cancer deaths due to higher BMI in those born in 1970 to 1974
Tooth Loss May Up Pancreatic Cancer Risk in Black Women
Pancreatic cancer risk increased with tooth loss, especially loss of five or more teeth
USPSTF Still Recommends Against Pancreatic Cancer Screening
No evidence seen for benefits of pancreatic cancer screening, treatment of screen-detected cancer
Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events
